Adenosquamous Carcinoma of the Pancreas
Showing 1 - 25 of 9,521
Adenosquamous Carcinoma of the Pancreas Trial run by the NCI (Minnelide)
Recruiting
- Adenosquamous Carcinoma of the Pancreas
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 7, 2022
Pancreatic Cancer, Adenocarcinoma of the Pancreas, Squamous Cell Carcinoma of Pancreas Trial in Boston (ZIMBERELIMAB,
Recruiting
- Pancreatic Cancer
- +3 more
- ZIMBERELIMAB
- +3 more
-
Boston, MassachusettsDana Farber Cancer Institute
Jan 9, 2023
Pancreatic Acinar Cell Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenosquamous Carcinoma Trial (Nab paclitaxel,
Not yet recruiting
- Pancreatic Acinar Cell Carcinoma
- +6 more
- Nab paclitaxel
- +5 more
- (no location specified)
Oct 30, 2023
Renal Cell Carcinoma Metastases to Pancreas
Completed
- Surgery
- (no location specified)
May 21, 2023
Use Of Indocyanine Green In Pancreas Surgery
Not yet recruiting
- Pancreatic Carcinoma
- Non-Interventional Study
-
Portland, OregonOHSU Knight Cancer Institute
Oct 11, 2023
ESCC or Esophageal Adenosquamous Carcinoma Trial in Guangzhou (HLX07+HLX10+ Cisplatin+5-FU, HLX07)
Recruiting
- ESCC or Esophageal Adenosquamous Carcinoma
- HLX07+HLX10+ Cisplatin+5-FU
- HLX07
-
Beijing, Beijing, China
- +16 more
Aug 25, 2022
Neuroendocrine Carcinoma of Pancreas, Duodenum Carcinoma, Pancreas Tumor Trial in Amsterdam, Rotterdam (Stereotactic
Recruiting
- Neuroendocrine Carcinoma of Pancreas
- +6 more
- Stereotactic radiotherapy
-
Amsterdam, North-Holland, Netherlands
- +1 more
Nov 29, 2022
Sputum DNA Testing for Lung Cancer in China
Recruiting
- Lung Cancer
- +15 more
- Diagnostic Test: Sputum DNA methylation analysis
- chest CT or pathological examination
-
Guangzhou, Guangdong, ChinaNanfang Hospital of Southern Medccal University
Dec 29, 2022
HPV-Associated Cervical Carcinoma, HPV-Related Carcinoma, HPV-Related Malignancy Trial in New Brunswick (Conditioning, E7 TCR-T
Not yet recruiting
- HPV-Associated Cervical Carcinoma
- +16 more
- Conditioning, E7 TCR-T cells, and aldesleukin
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Jan 17, 2023
Radiotherapy - Comprehensive Radiobiology Assessment TRial
Not yet recruiting
- Locally Advanced Cervical Carcinoma
- +9 more
-
Saint Louis, MissouriWashington University School of Medicine
Aug 1, 2023
Head Neck Cancer, Cervical Cancer, Non-small Cell Carcinoma Trial in Scottsdale, Chapel Hill (TSC-204-A0201, TSC-204-C0702,
Not yet recruiting
- Head and Neck Cancer
- +20 more
- TSC-204-A0201
- +4 more
-
Scottsdale, Arizona
- +1 more
Aug 3, 2023
Cervical Cancer, Throat Cancer, Oropharynx Cancer Trial in New Brunswick (E7 TCR-T cells)
Not yet recruiting
- Cervical Cancer
- +20 more
- E7 TCR-T cells
-
New Brunswick, New Jersey
- +1 more
Jan 18, 2023
Stage IV Cervical Cancer FIGO 2018, Adenosquamous Carcinoma of Cervix, Cervical Cancer Trial in Dallas (Ultra-fractionated
Recruiting
- Stage IV Cervical Cancer FIGO 2018
- +3 more
- Ultra-fractionated radiation therapy
-
Dallas, TexasUT Southwestern Medical Center
Apr 29, 2022
Cervical Carcinoma, Adenocarcinoma, Adenosquamous Carcinoma Trial in France, Italy, Spain (Standard treatment: Control arm,
Not yet recruiting
- Cervical Carcinoma
- +2 more
- Standard treatment: Control arm
- Experimental arm
-
Bordeaux, France
- +18 more
Oct 12, 2022
Human Papilloma Virus Circulating Tumor DNA in Cervical Cancer
Recruiting
- Cervical Adenosquamous Carcinoma
- +26 more
- Biospecimen Collection
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
Hybrid PET/MR in the Therapy of Cervical Cancer
Completed
- Cervix Carcinoma
- +2 more
- FDG PET/MR
-
Chapel Hill, North CarolinaUniversity of North Carolina-Chapel Hill
Dec 2, 2021
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified Trial in
Recruiting
- Cervical Adenocarcinoma
- +11 more
- Media Intervention
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Jun 15, 2022
Ampullary Cancer, Bile Duct Cancer, Pancreas Cancer Trial in Zhanjiang (Modified Blumgart Anastomosis in LPD, conventional
Enrolling by invitation
- Ampullary Cancer
- +3 more
- Modified Blumgart Anastomosis in LPD
- conventional Blumgart anastomosis in LPD
-
Zhanjiang, Guangdong, ChinaThe Affiliated Hospital of Guangdong Medical University
Oct 7, 2023
Advanced Solid Tumor, CDKN2A, NSCLC Trial (Milademetan, Atezolizumab)
Withdrawn
- Advanced Solid Tumor
- +9 more
- (no location specified)
Oct 16, 2023
Pancreas Cancer, Non-Resectable Pancreas Carcinoma Trial in Aalborg (Gemcitabine, Nab paclitaxel)
Not yet recruiting
- Pancreas Cancer
- Non-Resectable Pancreas Carcinoma
- Gemcitabine
- Nab paclitaxel
-
Aalborg, DenmarkDepartment of Oncology, Aalborg University Hospital
May 1, 2023
Cervical Adenocarcinoma, Cervical Adenosarcoma, Cervical Adenosquamous Carcinoma Trial in United States (biological, other,
Recruiting
- Cervical Adenocarcinoma
- +47 more
- Bevacizumab
- +3 more
-
Phoenix, Arizona
- +3 more
Dec 5, 2022
Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in United States
Completed
- Endometrial Adenocarcinoma
- +4 more
- Akt Inhibitor MK2206
- Laboratory Biomarker Analysis
-
Boston, Massachusetts
- +6 more
Jan 13, 2022
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified Trial in
Withdrawn
- Cervical Adenocarcinoma
- +6 more
- Carboplatin
- +4 more
-
Cape Town, South Africa
- +2 more
Jun 14, 2022